Search Keyword:


Search option:


IID00962
UniprotQ00653
ProteinNuclear factor NF-kappa-B p100 subunit
GeneNFKB2
OrganismHomo sapiens
Sequence LLPS PhaSepDB
PhaSePro
LLPSDB
DrLLPS
Network xml rdf
Structure
Experiment
  :order   disorder   conflict   PDB cluster   ProS   Pfam Domain   SEG
900
 order/disorder by at least rule
     disorder by at least rule
     order by at least rule
 order/disorder by majority rule
Seq 1-398 Homo dimer :
 Evidence X-RAY 1a3q A Reference
       Region 1a3q A 37-199 order
       Region 1a3q A 206-327 order
 Evidence X-RAY 1a3q B Reference
       Region 1a3q B 37-199 order
       Region 1a3q B 206-327 order
 Evidence X-RAY 7cli A Reference
       Region 7cli A 1-34 disorder
       Region 7cli A 35-161 order
       Region 7cli A 162-164 disorder
       Region 7cli A 165-329 order
       Region 7cli A 330-398 disorder
 Evidence X-RAY 7cli B Reference
       Region 7cli B 1-33 disorder
       Region 7cli B 34-329 order
       Region 7cli B 330-398 disorder
 Evidence X-RAY 7vup A Reference
       Region 7vup A 1-33 disorder
       Region 7vup A 34-329 order
       Region 7vup A 330-398 disorder
 Evidence X-RAY 7vup B Reference
       Region 7vup B 1-33 disorder
       Region 7vup B 34-329 order
       Region 7vup B 330-398 disorder
 Evidence X-RAY 7vuq A Reference
       Region 7vuq A 1-33 disorder
       Region 7vuq A 34-329 order
       Region 7vuq A 330-398 disorder
 Evidence X-RAY 7vuq B Reference
       Region 7vuq B 1-33 disorder
       Region 7vuq B 34-329 order
       Region 7vuq B 330-398 disorder
 Evidence X-RAY 7w7l A Reference
       Region 7w7l A 1-32 disorder
       Region 7w7l A 33-326 order
       Region 7w7l A 327-327 disorder
 Evidence X-RAY 7w7l B Reference
       Region 7w7l B 1-33 disorder
       Region 7w7l B 34-327 order
Seq 35-329 Hetero dimer : IID00025Complex
 Evidence X-RAY 5zmc A Reference
       Region 5zmc A 35-225 disorder
       Region 5zmc A 226-328 order
       Region 5zmc A 329-329 disorder
Seq 37-329 Hetero dimer : Q04863
 Evidence X-RAY 3do7 B Reference
       Region 3do7 B 37-329 order
Seq 407-765 Homo dimer :
 Evidence X-RAY 4ot9 A Reference
       Region 4ot9 A 407-434 disorder
       Region 4ot9 A 435-701 order
       Region 4ot9 A 702-725 disorder
       Region 4ot9 A 726-756 order
       Region 4ot9 A 757-765 disorder
Seq 766-859 Monomer :
 Evidence NMR 2d96 A Reference
       Region 2d96 A 766-859 order
       Region 2d96 A 851-859 high_rmsd
SeqProS verified 37-225 DNA binding Hetero dimer : Q04863
       Region 3do7 B 37-329 order
       Region 5zmc A 35-225 disorder
SeqProS verified 37-225 DNA binding; only representative PDB datasets are shown as ProS evidence. Homo dimer :
       Region 1a3q A 37-199 order
       Region 1a3q A 206-327 order
       Region 1a3q B 37-199 order
       Region 1a3q B 206-327 order
       Region 7cli A 35-161 order
       Region 7cli A 165-329 order
       Region 7cli B 34-329 order
       Region 5zmc A 35-225 disorder
Seqphosphorylation
    870-870 Phosphoserine; by MAP3K14
    866-866 Phosphoserine; by MAP3K14
    812-812 Phosphoserine
    717-717 Phosphoserine
    715-715 Phosphoserine
    713-713 Phosphoserine
    429-429 Phosphothreonine
    161-161 Phosphoserine
    23-23 Phosphoserine
 
Prediction
NeProc
Disorder 1-35,343-455,700-729,735-770,857-900
Order 36-342,456-699,730-734,771-856
ProS 2-24,343-357,364-425,437-455,700-704,726-729,735-749,857-871,884-900
AlphaFold
Disorder 1-36,61-62,163-163,267-268,330-436,516-517,701-728,752-770,784-789,849-900
Order 37-60,63-162,164-266,269-329,437-515,518-700,729-751,771-783,790-848
Pfam Hmmer
228->326 40-220 487->522
SEG 351-377 ,391-409 ,697-723 ,756-771 ,822-835 ,880-895
Function
Function in SwissProt
NF-kappa-B is a pleiotropic transcription factor present in almost all cell types and is the endpoint of a series of signal transduction events that are initiated by a vast array of stimuli related to many biological processes such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. NF-kappa-B is controlled by various mechanisms of post-translational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. NF-kappa-B complexes are held in the cytoplasm in an inactive state complexed with members of the NF-kappa-B inhibitor (I-kappa-B) family. In a conventional activation pathway, I-kappa-B is phosphorylated by I-kappa-B kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NF-kappa-B complex which translocates to the nucleus. In a non-canonical activation pathway, the MAP3K14-activated CHUK/IKKA homodimer phosphorylates NFKB2/p100 associated with RelB, inducing its proteolytic processing to NFKB2/p52 and the formation of NF-kappa-B RelB-p52 complexes. The NF-kappa-B heterodimeric RelB-p52 complex is a transcriptional activator. The NF-kappa-B p52-p52 homodimer is a transcriptional repressor. NFKB2 appears to have dual functions such as cytoplasmic retention of attached NF-kappa-B proteins by p100 and generation of p52 by a cotranslational processing. The proteasome-mediated process ensures the production of both p52 and p100 and preserves their independent function. p52 binds to the kappa-B consensus sequence 5'-GGRNNYYCC-3', located in the enhancer region of genes involved in immune response and acute phase reactions. p52 and p100 are respectively the minor and major form; the processing of p100 being relatively poor. Isoform p49 is a subunit of the NF-kappa-B protein complex, which stimulates the HIV enhancer in synergy with p65. In concert with RELB, regulates the circadian clock by repressing the transcriptional activator activity of the CLOCK-BMAL1 heterodimer.